KLOW

Research Notes

The most comprehensive beauty-research blend in the IRIX lineup: GHK-Cu, BPC-157, TB-500, and KPV in a single vial. Each compound addresses a distinct mechanism — collagen and elastin signaling (GHK-Cu), angiogenesis and tissue repair (BPC-157), cell migration and actin binding (TB-500), and melanocortin-driven anti-inflammatory activity (KPV). KLOW is designed for researchers studying how these four pathways interact when presented together. What the research explores: the intersection of copper-peptide collagen signaling with inflammatory regulation, how KPV's MC1R and MC3R activity modifies the repair environment created by BPC-157 and TB-500, and whether combined multi-pathway stimulation produces different outcomes than the individual compounds studied in isolation. What it isn't: a skincare product, a therapeutic blend, or a finished compound with its own clinical evidence base. As with all multi-peptide research materials, KLOW is for laboratory use only — the interest is in studying these mechanisms together, not applying this blend outside a controlled research context.